Prevention of Human Immunodeficiency Virus Type 1 Transmission by Pharmaceuticals Targeted to Host Proteins Required for Virus Infection? Consideration of Farnesyl Thiosalicylic Acid, a Ras Inhibitor
1997 ◽
Vol 71
(5)
◽
pp. 3932-3939
◽
2003 ◽
Vol 77
(15)
◽
pp. 8237-8248
◽
1994 ◽
Vol 91
(21)
◽
pp. 9770-9774
◽
2007 ◽
Vol 88
(11)
◽
pp. 3139-3144
◽
1998 ◽
Vol 178
(3)
◽
pp. 862-865
◽
1995 ◽
Vol 270
(41)
◽
pp. 23883-23886
◽
2000 ◽
Vol 61
(3)
◽
pp. 347-351
◽